Study

HIIT in Cancer: Better Fitness & Function Compared to Conventional Endurance Training?

HIIT improves function and VO₂ in cancer patients; compared to MICT, a benefit for VO₂ is observed (SMD 0.37; p=0.009). Training effects increase with total volume.

Lesezeit:

10

min.

Why This Matters

Cancer and cancer treatments are often associated with reduced performance, fatigue, and cardiovascular risks. Targeted endurance training is part of modern oncology programs – but which format is more effective? This study compares high-intensity interval training (HIIT) with moderate-intensity continuous training (MICT).

Study Design (in brief)

Type: Systematic review and meta-analysis according to PRISMA.
Inclusion: RCTs with HIIT in adult cancer patients; for the meta-analysis, only trials with direct comparisons of HIIT vs. MICT were included.
Endpoints: Functional tests (e.g., 6-Minute Walk Test, Sit-and-Reach, Sit-to-Stand, TUG) and VO₂peak/VO₂max.

Key Findings

Functional Performance

  • 6-Minute Walk Test: mean improvement +8.63 ± 6.91%.

  • Mobility (Sit-and-Reach): +2.7 cm.
    → Both significantly improved after HIIT interventions.

Cardiopulmonary Fitness (VO₂)

  • Relative VO₂peak increased with HIIT: +10.68 ± 6.48%.

  • Relative VO₂peak with MICT: +7.40 ± 4.29%.

  • Meta-analysis HIIT vs. MICT: SMD 0.37 (95% CI 0.09–0.65), p=0.009, I²=0% → favors HIIT.

Dose–Response
Effect size (ES) of VO₂ improvement correlated moderately with total training volume (ρ=0.49; p=0.03), but not with percentage increase (ρ=0.24; p=0.14).
Interpretation: Not only intensity but also total training time matters.

Practical Implications & Programming

Who benefits?
Broad spectrum: pre-, peri-, and post-treatment; UICC stages I–IV in included RCTs. Safety and feasibility of HIIT in cancer patients have been repeatedly demonstrated.

Implementation (FITT principles from RCTs):

  • Frequency: usually 2–3×/week, ≥3 weeks intervention duration.

  • Intensity: intervals often at ≥85–95% VO₂peak/HRpeak, active recovery at 50–70%.

  • Time: typical sets: 4×4 min or 30–60 s sprints; session duration ~30–40 min.

  • Type: treadmill or cycle ergometer; consider oncological context (e.g., fatigue diary, hematology check).

Expected Outcomes (realistic):

  • Quickly noticeable: walking distance, mobility.

  • Measurable in lab: VO₂peak increase – generally greater with HIIT than with MICT.

  • Programming tip: progressively increase volume (correlates with effect size).

Limitations of Evidence

  • Heterogeneous protocols (interval duration, devices, frequency).

  • Functional outcomes less frequently compared directly between HIIT and MICT than VO₂.

  • Need for longer follow-up and standardized functional outcome measures.

Autoren

T. Neuendorf; R. Haase; S. Schroeder; M. Schumann; N. Nitzsche

Publikations Details

Studientyp:

Systematic Review & Meta-Analysis (RCTs).

Publikation:

Supportive Care in Cancer (2023); 31:643. Online publication: October 18, 2023.

Teilnehmer:

(overall/meta): n=1,555 (31 RCTs) / n=268 (8 RCTs, relative VO₂peak)

Ort:

Chemnitz University of Technology; German Sport University Cologne (Germany)

DOI:

10.1007/s00520-023-08103-9

10.1007/s00520-023-08103-9

PubMed ID:

37851104

37851104

Auf PubMed öffnen

Weitere Studien und Ressourcen finden Sie hier.

Weitere Studien und Ressourcen finden Sie hier.

Weiterlesen